Related Experiment Video
Updated: Dec 15, 2025

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release
Published on: February 13, 2016
Magnetically active pNIPAM nanosystems as temperature-sensitive biocompatible structures for controlled drug delivery
Beatriz Garcia-Pinel1,2,3, Alicia Ortega-Rodríguez4, Cristina Porras-Alcalá4
1Institute of Biopathology and Regenerative Medicine (IBIMER), Center of Biomedical Research (CIBM), University of Granada, Granada, Spain.
New magnetic nanoparticles offer controlled drug delivery for colon cancer. These biocompatible poly(N-isopropylacrylamide) (pNIPAM) nanosystems effectively deliver 5-fluorouracil (5FU) and oxaliplatin (OXA), showing promise for improved cancer treatment.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Drug Delivery Systems
Background:
- Colon cancer treatment often involves chemotherapy with drugs like 5-fluorouracil (5FU) and oxaliplatin (OXA).
- Effective delivery of these chemotherapeutics is crucial for maximizing efficacy and minimizing side effects.
- Developing novel nanocarriers can enhance drug targeting and controlled release.
Purpose of the Study:
- To synthesize and investigate temperature-sensitive, magnetically responsive poly(N-isopropylacrylamide) (pNIPAM) nanosystems.
- To evaluate the controlled release of 5-fluorouracil (5FU) and oxaliplatin (OXA) using these nanosystems.
- To assess the biocompatibility and anti-cancer efficacy of the developed nanoformulations against colon cancer cells.
Main Methods:
- Synthesis of magnetic nanoparticles (@Fe3O4) via co-precipitation and functionalization.
- Free radical polymerization to grow thermo-responsive pNIPAM polymer chains.
- Characterization using Transmission Electron Microscopy (TEM), Dynamic Light Scattering (DLS), and Z-potential (ZP).
- Loading of 5FU and OXA, followed by drug release studies and cytotoxicity assays against T-84 colon cancer cells.
Main Results:
- Synthesized hybrid nanoparticles exhibited magnetic response and temperature sensitivity.
- pNIPAM nanoformulations demonstrated high biocompatibility with human blood and cultured cells.
- The pNIPAM@Fe3O4-3BA + 5FU formulation showed significant inhibition of T-84 cell proliferation (57%).
- pNIPAM-co-AL@Fe3O4-AA nanosystems facilitated cell migration under an external magnetic field.
Conclusions:
- The developed hybrid nanoparticles represent a promising biocompatible platform for colon cancer therapy.
- These nanosystems enable controlled delivery of 5FU and OXA, potentially improving treatment outcomes.
- Magnetic targeting offers a strategy for enhancing drug delivery efficiency in cancer treatment.
More Related Videos
08:39Magnetic and Thermal-sensitive PolyN-isopropylacrylamide-based Microgels for Magnetically Triggered Controlled Release
Published on: July 4, 2017
09:01Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
Published on: May 22, 2020